Home / Companies / DaShenLin Pharmaceutical Group Co., Ltd. / 30 Mar 2026
DaShenLin Pharmaceutical Group Co., Ltd.: meeting of 30 Mar 2026
Votes reported on Form N-PX, item by item
20 Form N-PX filers reported votes at the DaShenLin Pharmaceutical Group Co., Ltd. meeting of 30 Mar 2026. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
7 nominees; 99.3% of reported votes for; one filer withheld from or voted against at least one nominee.
168 vote records from 20 filers. 0 of the 18 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
48 vote records from 20 filers. 0 of the 18 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors |
|---|---|
| Vanguard | For |
| Dimensional | For |
| State Street and SPDR | For |
| Equitable | For |
| Charles Schwab | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| Goldman Sachs | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| Brighthouse Funds | For |
| BNY Mellon | Split or no vote |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the DaShenLin Pharmaceutical Group Co., Ltd. meeting?
20 Form N-PX filers reported votes at the meeting of 30 Mar 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by DaShenLin Pharmaceutical Group Co., Ltd. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for DaShenLin Pharmaceutical Group Co., Ltd.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing DaShenLin Pharmaceutical Group Co., Ltd. with a meeting date within three days of 30 Mar 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.